Amgen (MEX:AMG N) Total Assets : MXN1,789,514 Mil (As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Amgen Total Assets?

Amgen's Total Assets for the quarter that ended in Sep. 2024 was MXN1,789,514 Mil.

Warning Sign:

If a company builds assets at 13.8% a year, faster than its revenue growth rate of 8% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Amgen's average Total Assets Growth Rate was 46.70% per year. During the past 3 years, the average Total Assets Growth Rate was 18.10% per year. During the past 5 years, the average Total Assets Growth Rate was 13.80% per year. During the past 10 years, the average Total Assets Growth Rate was 5.50% per year.

During the past 13 years, Amgen's highest 3-Year average Total Assets Growth Rate was 93.20%. The lowest was -5.40%. And the median was 12.70%.

Total Assets is connected with ROA %. Amgen's annualized ROA % for the quarter that ended in Sep. 2024 was 12.90%. Total Assets is also linked to Revenue through Asset Turnover. Amgen's Asset Turnover for the quarter that ended in Sep. 2024 was 0.10.

Amgen Total Assets Historical Data

The historical data trend for Amgen's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amgen Total Assets Chart

Amgen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

1,126,074.02

1,252,161.62

1,254,738.81

1,269,599.02

1,649,116.09

Amgen Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															1,577,002.42	1,649,116.09	1,543,119.79	1,665,425.61	1,789,513.54

Amgen Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Amgen's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	105783.513	+	1543332.576
	=	1,649,116

Amgen's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	148208.888	+	1641304.648
	=	1,789,514

Amgen (MEX:AMG N) Total Assets Explanation

Total Assets is connected with ROA %.

Amgen's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	222894.196	/	( (1665425.605	+	1789513.536)	/ 2 )
	=	222894.196	/	1727469.5705
	=	12.90 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Amgen's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	167426.621	/	( (1665425.605	+	1789513.536)	/ 2 )
=	167426.621	/	1727469.5705
=	0.10

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Amgen Total Assets Related Terms

Thank you for viewing the detailed overview of Amgen's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Amgen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amgen Inc (MEX:AMG N) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

AMGN:USA 1AMGN:Italy AMGd:UK AMG:Germany AMG:Germany AMG:Germany AMG:Germany AMGN:Chile AMGN34:Brazil AMGN:Austria AMGN:Argentina

Address

One Amgen Center Drive, Thousand Oaks, CA, USA, 91320-1799

Website

https://www.amgen.com

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen Headlines

No Headlines